Ohishi, Masanobu <br/><br/>
Osteoprotegerin abrogated cortical porosity and bone marrow fibrosis in a mouse model of constitutive activation of the PTH/PTHrP receptor.  [electronic resource] 

 -  The American journal of pathology  Jun 2009 
 - 2160-71 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1525-2191 
<br/><br/><label>Standard No.: </label>10.2353/ajpath.2009.081026  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Alendronate--pharmacology<br/>Animals<br/>Biomechanical Phenomena<br/>Bone Resorption--metabolism<br/>Bone and Bones--drug effects<br/>Diphosphonates--pharmacology<br/>Disease Models, Animal<br/>Humans<br/>Hyperparathyroidism--metabolism<br/>Imidazoles--pharmacology<br/>Immunohistochemistry<br/>Male<br/>Mice<br/>Mice, Transgenic<br/>Osteoclasts--drug effects<br/>Osteoprotegerin--metabolism<br/>Porosity<br/>Primary Myelofibrosis--metabolism<br/>Receptor, Parathyroid Hormone, Type 1--genetics<br/>Tomography, X-Ray Computed<br/>Zoledronic Acid